Connect with us

Business Wire

Organigram and InterCure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies

Published

on


Organigram to supply Israeli pharmaceutical grade cannabis leader InterCure with up to 20,000 kg of dried flower over multiple years

TORONTO & HERZILA, Israel–(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), ( “Organigram”) a leading Canadian licensed producer of cannabis and Canndoc Ltd. (“Canndoc”), a subsidiary of InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) (dba Canndoc) Israel’s largest and most established pharmaceutical cannabis producer, today jointly announced that they have entered into a new multi-year agreement (the “New Strategic Agreement”) for Organigram to continue supply of dried flower to InterCure.

Organigram and InterCure entered into a previous strategic supply agreement in June 2020, (the “First Strategic Agreement”) that contemplated a minimum supply of 3,000 kg all of which has been fulfilled. The New Strategic Agreement contemplates up to 20,000 kg to be supplied to InterCure’s international supply chain. Specifically, the New Strategic Agreement provides for a commitment of 10,000kg with an option for Canndoc to elect to order up to an additional 10,000kg from Organigram during the three-year term (the “Term”). Approximately 2,800 kg has already been delivered to Canndoc from Organigram since July 2022 and credited against the total volume commitment under the New Strategic Agreement.

Based on the success of the First Strategic Agreement and the desire of the parties to continue to collaborate and grow their businesses, the New Strategic Agreement was entered into. Subject to the terms and conditions of the New Strategic Agreement, Organigram has agreed to exclusively supply InterCure in Israel for the Term. Additionally, the parties agreed on certain popular genetics which will be exclusively supplied for distribution into InterCure’s international supply chain, subject to local regulations.

“Our business with InterCure a leader in pharmaceutical grade cannabis, has been mutually beneficial and we are excited to expand the relationship going forward,” said Beena Goldenberg, Chief Executive Officer of Organigram. “This new Strategic agreement envisions a significantly greater amount of dried flower to be shipped from Organigram to Canndoc and allows us to collaborate in the future on other emerging medical cannabis markets in European jurisdictions.”

“Establishing exclusive long term strategic partnerships with world-class partners supports our international expansion plans and profitable growth strategy,” says Alex Rabinovitch, CEO, InterCure. “We are proud to expand our long and fruitful partnership with Organigram, a pioneering multinational operator which shares our commitment of providing the highest quality pharmaceutical grade medical cannabis products to patients around the globe.”

Activities under the New Strategic Agreement are subject to compliance with all applicable laws, including receipt of all requisite approvals and permits for each proposed shipment from all applicable regulatory authorities including the Israeli Ministry of Health and Health Canada.

About Organigram Holdings Inc.

Organigram Holdings Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly-owned subsidiaries include: Organigram Inc. and Laurentian Organic Inc. licensed producers of cannabis and cannabis-derived products in Canada, and The Edibles and Infusions Corporation, a licensed manufacturer of cannabis-infused edibles in Canada.

Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Company’s global footprint. Organigram has also developed a portfolio of legal adult-use recreational cannabis brands, including Edison, Big Bag O’ Buds, SHRED, Monjour and Trailblazer. Organigram operates facilities in Moncton, New Brunswick and Lac-Supérieur, Québec, with a dedicated manufacturing facility in Winnipeg, Manitoba. The Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).

This news release contains forward-looking information. Forward-looking information, in general, can be identified by the use of forward-looking terminology such as “outlook”, “objective”, “may”, “will”, “could”, “would”, “might”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “plan”, “continue”, “budget”, “schedule” or “forecast” or similar expressions suggesting future outcomes or events. They include, but are not limited to, statements with respect to expectations, projections or other characterizations of future events or circumstances, and the Company’s objectives, goals, strategies, beliefs, intentions, plans, estimates, forecasts, projections and outlook, including statements relating to the Company’s international sales, These statements are not historical facts but instead represent management beliefs regarding future events, many of which, by their nature are inherently uncertain and beyond management control. Forward-looking information has been based on the Company’s current expectations about future events.

Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectations. Important factors – including impact on demand for products, general economic factors; receipt of regulatory approvals or consents and any conditions imposed upon same and the timing thereof, ability to meet regulatory criteria which may be subject to change, regulatory uncertainty related to importations, ordering patterns, factors that may influence the exercise of the option by Canndoc and transportation risks, that could cause actual results to differ materially from the Company’s expectations are disclosed in the Company’s documents filed from time to time under the Company’s issuer profile on the Canadian Securities Administrators’ System for Electronic Document Analysis and Retrieval (“SEDAR”) at www.sedar.com and reports and other information filed with or furnished to the United States Securities and Exchange Commission (“SEC”) from time to time on the SEC’s Electronic Document Gathering and Retrieval System (“EDGAR”) at www.sec.gov, including the Company’s most recent AIF. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this news release. The Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

About InterCure and Canndoc

InterCure (dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) is a cannabis company outside of North America. Canndoc, a wholly owned subsidiary of InterCure, is Israel’s largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated “seed-to-sale” model to lead the fastest growing cannabis global market outside of North America.

For more information visit: https://www.canndoc-pharma.com/ and http://www.intercure.co

Contacts

For Investor Relations enquiries:

investors@organigram.ca

For Media enquiries:

Paolo De Luca, Chief Strategy Officer

paolo.deluca@organigram.ca

InterCure Ltd.

Amos Cohen, Chief Financial Officer

amos@intercure.co
Phone – +972-58-666-8686

This post was originally published on this site



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business Wire

Cannabis Cultivation Global Market Report 2022: Increasing Use of Cannabis as a Treatment for Chronic Disease Boosts Growth – ResearchAndMarkets.com

Published

on

By


DUBLIN–(BUSINESS WIRE)–The “Cannabis Cultivation Global Market Report 2022: Ukraine-Russia War Impact” report has been added to ResearchAndMarkets.com’s offering.

The global cannabis cultivation market is expected to grow from $114.66 billion in 2021 to $132.55 billion in 2022 at a compound annual growth rate (CAGR) of 15.6%. The cannabis cultivation market is expected to grow to $235.74 billion in 2026 at a compound annual growth rate (CAGR) of 15.5%.

Asia Pacific was the largest region in the cannabis cultivation market in 2021. The regions covered in the cannabis cultivation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Adoption of cannabis for the treatment of chronic diseases is expected to propel the growth of the cannabis cultivation market going forward. Chronic disease refers to a medical condition that lasts for a year or longer and necessitates continuing medical care and restricts daily activities. Adoption of cannabis for the treatment of chronic diseases helps cannabis cultivation by demonstrating safety, efficacy, and consistency sufficient for regulatory approval in spasticity in chronic diseases such as multiple sclerosis, and Dravet and Lennox-Gastaut Syndromes.

For instance, in March 2022, according to the data published in the annual report of Jazz Pharmaceuticals plc, an Ireland-based biopharmaceutical company, the company generated a net sale of $463.6 million for Epidiolex, in 2021, with a year-on-year sales growth of 29% as compared to previous year i.e., 2020. Therefore, the adoption of cannabis for the treatment of chronic diseases is driving the cannabis cultivation market.

Product innovations are a key trend gaining popularity in the cannabis cultivation market. Major companies operating in the cannabis cultivation market are focused on developing innovative products to strengthen their position in the cannabis cultivation market.

For instance, in January 2022, Prospiant, a US-based controlled environment agriculture (CEA) greenhouse solutions and cannabis cultivation and extraction technologies provider, launched Delta Ethanol Extraction CUP-5 to specifically meet the requirements of prototype labs, educational research centers, and small-scale cannabis processing facilities. During the process of cannabis cultivation, it can handle plant material in batches as small as 3.5 pounds and finish the extraction process in 2 to 12 minutes. It combines mechanical centrifugation with closed-loop cold alcohol extraction technology to produce a high-purity final product. Its innovative features also include the ability to operate without a C1D2 environment or a hazardous location (HazLoc) requirement.

Scope

Markets Covered:

1) By Type: Cannabis Indica; Cannabis Sativa

2) By Source: Flower or Buds; Leaves; Other Sources

3) By Application Outlook : Medical Consumption; Recreational Consumption; Industrial Consumption

Key Topics Covered:

1. Executive Summary

2. Cannabis Cultivation Market Characteristics

3. Cannabis Cultivation Market Trends And Strategies

4. Cannabis Cultivation Market – Macro Economic Scenario

5. Cannabis Cultivation Market Size And Growth

6. Cannabis Cultivation Market Segmentation

7. Cannabis Cultivation Market Regional And Country Analysis

8. Asia-Pacific Cannabis Cultivation Market

9. China Cannabis Cultivation Market

10. India Cannabis Cultivation Market

11. Japan Cannabis Cultivation Market

12. Australia Cannabis Cultivation Market

13. Indonesia Cannabis Cultivation Market

14. South Korea Cannabis Cultivation Market

15. Western Europe Cannabis Cultivation Market

16. UK Cannabis Cultivation Market

17. Germany Cannabis Cultivation Market

18. France Cannabis Cultivation Market

19. Eastern Europe Cannabis Cultivation Market

20. Russia Cannabis Cultivation Market

21. North America Cannabis Cultivation Market

22. USA Cannabis Cultivation Market

23. South America Cannabis Cultivation Market

24. Brazil Cannabis Cultivation Market

25. Middle East Cannabis Cultivation Market

26. Africa Cannabis Cultivation Market

27. Cannabis Cultivation Market Competitive Landscape And Company Profiles

28. Key Mergers And Acquisitions In The Cannabis Cultivation Market

29. Cannabis Cultivation Market Future Outlook and Potential Analysis

30. Appendix

Companies Mentioned

  • Pacific Cannabis Growers Inc
  • Atlas Growers
  • Canntrust Holdings Inc
  • The Hydropothecary Corporation
  • Better Holdings

For more information about this report visit https://www.researchandmarkets.com/r/g15ok7

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

This post was originally published on this site



Source link

Continue Reading

Business Wire

$10.95 Billion Worldwide Food Grade Alcohol Industry to 2027 – Featuring Cargill, Cristalco, Glacial Grain Spirits and Pure Alcohol Solutions Among Others – ResearchAndMarkets.com

Published

on

By


DUBLIN–(BUSINESS WIRE)–The “Food Grade Alcohol Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering.

The global food grade alcohol market reached a value of US$ 7.84 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 10.95 Billion by 2027, exhibiting a CAGR of 5.73% during 2021-2027.

Companies Mentioned

  • Archer-Daniels-Midland Company
  • Cargill Incorporated
  • Cristalco
  • Ethimex Ltd
  • Extractohol
  • Glacial Grain Spirits
  • Grain Processing Corporation (Kent Corporation)
  • Manildra Group
  • MGP Ingredients Inc.
  • Molindo Group
  • Pure Alcohol Solutions
  • Roquette Freres
  • Wilmar Sugar Pty Ltd. (Wilmar International Limited)

Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.

Food grade alcohol is obtained by the fermentation of starch-containing plants, such as cereals, beets, or sugarcane, using yeast cells. It is widely employed in the food and beverage (F&B) industry to serve as a base for distilled spirits, such as vodka, gin and liqueurs, and a solvent for colorants and flavors in different food products. Besides this, it is used by bakers for decorating cakes through airbrushing.

The increasing consumption of alcoholic beverages across the globe represents one of the key factors impelling the growth of the market.

Moreover, food grade alcohol is used to extract cannabis oil from hemp or cannabis biomass as it is healthier and safer to handle than other hydrocarbon extraction methods. It is also considered ideal for small, medium, and large-scale hemp processors on account of its high evaporation rate and ease of separation from cannabis oil.

Additionally, the rising development of therapies and other consumer products derived from cannabis and its components, including cannabidiol (CBD) is catalyzing the demand for food grade alcohol worldwide.

Apart from this, it is extensively utilized in the pharmaceutical industry for decongestants, pills, vitamins, cough syrup preparations, and iodine solutions. This can be accredited to its coating, sweetening, emollient, bulking, anti-crystallizing, and stabilizing properties.

Furthermore, there is a rise in the popularity of nutraceutical products on account of their antiviral, anti-inflammatory, and immunomodulatory properties. This, coupled with the burgeoning pharmaceutical industry, is creating a positive outlook for the market. Other factors, including the increasing western influence and rising popularity of craft beer among millennials, are anticipated to facilitate the growth of the market.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global food grade alcohol market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, source, function and application.

Breakup by Product:

Breakup by Source:

  • Molasses and Sugarcane
  • Fruits
  • Grains
  • Others

Breakup by Function:

  • Coatings
  • Preservative
  • Coloring and Flavoring Agent
  • Others

Breakup by Application:

  • Healthcare and Pharmaceutical
  • Food
  • Beverages
  • Personal Care
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Key Questions Answered in This Report:

  • How has the global food grade alcohol market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global food grade alcohol market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the source?
  • What is the breakup of the market based on the function?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global food grade alcohol market and who are the key players?
  • What is the degree of competition in the industry?

For more information about this report visit https://www.researchandmarkets.com/r/fdsdai

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

This post was originally published on this site



Source link

Continue Reading

Business Wire

Cresco Labs Announces Conference Participation for December 2022

Published

on

By


CHICAGO–(BUSINESS WIRE)–Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), a vertically integrated multistate operator and the No. 1 U.S. wholesaler of branded cannabis products, today announced its executive team will participate in the following conferences this month:

Cowen Cannabis Conference, December 6-8, 2022 (Virtual): Chief Executive Officer Charles Bachtell will participate in a fireside chat moderated by Vivien Azer, Managing Director, on December 6 at 11:35 am EST. Management will participate in one-on-one meetings on December 6.

Stifel Future of Health Conference, December 7, 2022 (Virtual): Chief Executive Officer Charles Bachtell will participate in an MSO panel moderated by analyst Andrew Partheniou from 12:00 -12:55 pm EST, and management will participate in one-on-one meetings.

About Cresco Labs Inc.

Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy’s Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.

Contacts

Media:
Jason Erkes, Cresco Labs

Chief Communications Officer

press@crescolabs.com

Investors:
Megan Kulick, Cresco Labs

Senior Vice President, Investor Relations

investors@crescolabs.com

For general Cresco Labs inquiries:
312-929-0993

info@crescolabs.com

This post was originally published on this site



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media